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Expression of major histocompatibility complex (MHC) antigens on cancer cells is
essential for cell-mediated immune function.  However, these molecules are reduced on
cancer cells enabling them to escape from host immune surveillance.  It is well known
that interferon-gamma (IFN-γ) upregulates the expression of MHC molecules and
restores the immunogenicity of cancer cells.  Nevertheless, the mechanism by which
IFN-γ modulates MHC expression on cancer cells is not clear.  Therefore, in this report,
we examined the role of tyrosine protein kinases in IFN-γ-induced MHC expression in
a human lung adenocarcinoma cell line, HLC-1.  We found that a tyrosine protein
kinase inhibitor, herbimycin A, inhibited both IFN-γ-inducible MHC class I and class
II expression, as assessed by flow cytometry.  Additionally, assessment of tyrosine
phosphorylation of cellular substrates by confocal laser microscopy using an anti-
phosphotyrosine monoclonal antibody (mAb) revealed that IFN-γ induced protein
tyrosine phosphorylation within 5 min of treatment.  Herbimycin A inhibited this IFN-
γ-induced tyrosine phosphorylation.  Thus, tyrosine phosphorylation plays an important
role in IFN-γ-induced MHC class I and class II expression on HLC-1 cells.
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Major histocompatibility complex (MHC)
antigens on cancer cells are involved in a
variety of immune functions affecting tumor
immunity (Klein and Klein, 1985).  MHC class
I and II molecules present antigens to CD8+ and
CD4+ T cells in the form of peptide fragments
within their molecule-binding grooves, respec-
tively (Matsumura et al., 1992; Madden et al.,
1993; Stern et al., 1994).  MHC class I mole-
cules have been shown to act as restriction
elements in the lysis of target cells by cytotoxic
T lymphocytes (Lurquin et al., 1989), while
MHC class II molecules present antigens to
helper T cells and regulate autologous T helper
cell activation (Eckels et al., 1983).  Cancer cells,
however, have reduced expression of MHC
molecules, enabling them to escape from the
host’s immunosurveillance system (Goodenow
et al., 1985; Festenstein and Garrido, 1986).
Therefore, it is important to elucidate the mech-
anisms modulating the expression of MHC
molecules on cancer cells.
IFN-γ can restore the expression of MHC
molecules on many types of malignant cells.
Nevertheless the mechanisms of IFN-γ-induced
MHC expression on cancer cells have not been
elucidated, especially in the context of MHC
class I expression.  Recent biochemical studies
indicate that tyrosine phosphorylation of Janus
kinases (JAK) is an important step in the signal
transduction system activated by IFN-γ (Shuai
et al., 1993a; Darnell et al., 1994).  Further,
Hobart and colleagues (1997) suggested that
interferon regulatory factor 1 might regulate the
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expression of MHC class I and class II genes of
mice.  Therefore, in this report we examined the
role of tyrosine phosphorylation in the signal
transduction of IFN-γ-induced MHC expres-
sion in a human lung adenocarcinoma cell line,
HLC-1, using the tyrosine kinase inhibitor
herbimycin A.
Materials and Methods
Cells
HLC-1, a human lung adenocarcinoma cell line,
was cultured in a complete medium consisting
of RPMI 1640 (Kyokuto Pharmaceutical Indus-
trial Co., Ltd., Tokyo, Japan) supplemented with
10% heat-inactivated fetal calf serum (FCS) and
penicillin (100 mg/mL).
Reagents
Herbimycin A, an inhibitor of protein tyrosine
kinase, was purchased from Wako Pure Chemi-
cal (Osaka, Japan).  Recombinant human IFN-γ
was kindly supplied by Shionogi Pharmaceutical
Co., Ltd. (Osaka).
Antibodies
The following monoclonal antibodies (mAb)
were used:  fluorescein isothiocyanate (FITC)-
labeled W6/32 (Serotec, Oxford, United Kingdom)
against MHC class I; phycoerythrin (PE)-labeled
I3-RD1 (Coulter Immunology, Hialeah, FL)
against MHC class II; FITC-labeled 6D12
(MBL, Nagoya, Japan) against phosphotyro-
sine; MsIgG1-FITC (Coulter Immunology),
FITC-labeled anti-mouse immunoglobulin G1,
and MsIgG1-RD1 (Coulter Immunology), PE-
labeled anti-mouse immunoglobulin G1, as
controls for the FITC- and PE-labeled mAbs,
respectively.
Induction of MHC class I and II antigens
HLC-1 cells were cultured in the tissue culture
dish (Sumitomo Bakelite, Tokyo, Japan), 1 ×
105 cells/dish at 37°C for 24 h in a humidified
atmosphere of 5% CO2 in air.  The number of
cells and their viability were evaluated by the
trypan blue exclusion method.  Cells were pre-
treated for 2 h with or without various concen-
trations of herbimycin A before the addition of
IFN-γ.  After 1 h of incubation with or without
IFN-γ (1000 U/mL), cells were washed 3 times
with FCS-free medium and cultured in the
complete medium for an additional 48 h.
Flow cytometric analysis
Following incubation, HLC-1 cells were har-
vested with 0.02% EDTA (Cosmo Bio, Tokyo)
and then washed 3 times with phosphate-
buffered saline (PBS).  The cells were incubat-
ed with an appropriate dilution of mAb W6/32
and I3-RD1 or MsIgG1-FITC and MsIgG1-
RD1 for 30 min at 4°C.  After being washed 3
times with PBS, the cells were analyzed by flow
cytometry with the FACSort system (Becton
Dickinson, Mountain View, CA).  Data analy-
ses by fluorescence intensity were based on
calculating 1 × 104 cells per sample by the
LYSIS II software (Becton Dickinson).  These
series of experiments were repeated 3 times
with equivalent results.  The results were present-
ed as mean ± SE.
Laser microscopic analysis
HLC-1 cells were cultured in a glass-bottomed
microwell dish (MatTek Corp., Ashland, MA),
1 × 104 cells/dish at 37°C for 24 h in a humid-
ified atmosphere of 5% CO2 in air.  Cells were
pretreated for 2 h with or without herbimycin A
(0.1 mg/mL) before the addition of IFN-γ (1000
U/mL).  After being stimulated with IFN-γ,
cells were fixed with 70% ethanol.  After being
washed 3 times with PBS, the cells were incu-
bated with an appropriate dilution of mAb
6D12 for 30 min at 4°C.  After incubation, cells
were washed 3 times with PBS and analyzed by
confocal laser microscopy, ACAS Ultima
(Meridian Instruments, Okemos, MI).  These
series of experiments were also repeated 3
times with equivalent results, and the data pre-
sented were representative of one such experi-
ment.
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Results
Flow cytometric analysis
Cells were induced to express MHC antigens in
a dose-dependent manner following incubation
for 48 h in the presence of IFN-γ, 50, 100, 500,
1000 and 2000 U/mL.  The maximum expres-
sion was observed at IFN-γ concentrations of
1000 and 2000 U/mL (data not shown).  The
induction of the MHC expression was initially
observed after 12 h of exposure to IFN-γ; the
expression of MHC molecules gradually
intensified during 48 h of incubation (data not
shown).  IFN-γ at 2000 U/mL affected cell
growth and viability, so the cells were stimulat-
ed with IFN-γ at 1000 U/mL, followed by cul-
ture for 48 h.
HLC-1 cells had fundamentally reduced ex-
pression of MHC class I and II molecules.
However, when HLC-1 cells were stimulated
with IFN-γ, the expression of these molecules
increased immensely.  IFN-γ-inducible expres-
sion of MHC class I and class II molecules was
inhibited by herbimycin A.  Analysis of these
data by mean fluorescence intensity showed
that IFN-γ increased the expression of both
MHC class I and II molecules by 3.6 and 1.9
times respectively.  Herbimycin A inhibited
IFN-γ-inducible expression of MHC class I
molecules in a dose-dependent manner and
prevented IFN-γ-inducible expression of MHC
class II molecules (Figs. 1 and 2).
Laser microscopic analysis
After stimulation with IFN-γ (1000 U/mL),
tyrosine phosphorylation of cellular substrates
in HLC-1 cells was assessed by confocal laser
microscopy.  IFN-γ induced protein tyrosine
phosphorylation within 5 min (Fig. 3).  How-
ever, pretreatment of HLC-1 cells with herbi-
mycin A (0.1 μg/mL) appeared to prevent tyro-
sine phosphorylation.  Analyzing these data by
mean fluorescence intensity based on calculat-
ing 1 × 102 cells per sample (Fig. 4), protein
tyrosine phosphorylation by IFN-γ was observ-
ed within 1 min and peaked by 5 min.  After 15
min, protein tyrosine phosphorylation returned
to baseline levels as assessed by mean fluores-
cence intensity.  Herbimycin A almost com-
pletely inhibited the IFN-γ-inducible tyrosine
protein phosphorylation.
Fig. 1.  Interferon-gamma (IFN-γ) induced the ex-
pression of major histocompatibility complex (MHC)
class I molecules on HLC-1 cells.  The MHC expres-
sion was analyzed by FACsort system after 48 h ex-
position to IFN-γ.  Herbimycin A (0.0125–0.1 mg/mL)
prevented such expression in a dose-dependent manner.
Fig. 2.  Interferon-gamma (IFN-γ) induced the ex-
pression of major histocompatibility complex
(MHC) class II molecules on HLC-1 cells.  The
MHC expression was analyzed by FACsort system
after 48 h exposition to IFN-γ.  Herbimycin A
(0.0125–0.1 mg/mL) prevented such expression.
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Fig. 3.  Effects of herbimycin A on the interferon-
gamma (IFN-γ)-induced phosphorylation of tyro-
sine.  As shown in the upper panel, IFN-γ induced
phosphorylation of tyrosine on HLC-1 cells.  In the
lower panel, pretreatment with herbimycin A ap-
peared to inhibit the phosphorylation of tyrosine.
These findings indicate that IFN-γ induced
tyrosine phosphorylation of cellular substrates
which was inhibited by herbimycin A.
Discussion
Three intracellular signal transduction path-
ways have been considered in the induction of
MHC antigens by IFN-γ in several types of cells
(Koide et al., 1988; Klein et al., 1990; Nezu et al.,
1990; Towata et al., 1991; Lahat et al., 1993); that
is, the protein kinase A, Ca2+-calmodulin and
protein kinase C pathways. However, these
pathways have not been shown to be decisive
on the IFN-γ-induced expression of MHC class
I and II antigens.  There is only one report
which states that tyrosine kinase pathways may
be involved in the IFN-γ-induced expression of
MHC class II (Ryu et al., 1993).  Nevertheless,
the detailed signal transduction mechanisms
responsible for the IFN-γ-inducible expression
of MHC antigens on cancer cells have not been
elucidated, especially for MHC class I.
Recent biochemical studies have shown that
IFN-γ activated the JAK1 and JAK2 tyrosine
kinases which phosphorylate a down stream
signal transducer and activator of transcription
Fig. 4.  Effects of herbimycin A on interferon-
gamma (IFN-γ)-induced phosphorylation of tyro-
sine.  Analysis of tyrosine phosphorylation by mean
fluorescence intensity shows that IFN-γ increased
the tyrosine phosphorylation five fold within 5 min.
Herbimycin A inhibited the production of IFN-γ-
inducible phosphotyrosine.
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(STAT) in the IFN-γ response signal pathway.
Phosphorylated STAT1α dimerizes, translo-
cates to the nucleus, and binds specific DNA
elements, i.e., IFN-γ activation sites, thereby
activating transcription factors, e.g., interferon
regulatory factor 1 (Shuai et al., 1993a, 1993b;
Silvennoinen et al., 1993; Darnell et al., 1994;
Taniguchi et al., 1995).
We used an inhibitor of tyrosine protein
kinase, herbimycin A (Uehara et al., 1989;
Obinata et al., 1991), to determine whether
tyrosine phosphorylation may be involved in
the signal transduction for IFN-γ-induced ex-
pression of MHC class I and II molecules on
HLC-1 cells.  However, while herbimycin A is
useful in determining whether tyrosine phos-
phorylation is involved in the mechanisms for
activation by receptor-mediated signal transduc-
tion, it is not specific for JAK tyrosine kinases.
We observed that IFN-γ induced the expres-
sion of MHC class I and II on HLC-1 cells and
the phosphorylation of protein tyrosine in their
cellular substrates within 5 min.  Herbimycin A
inhibited both these expressions and the en-
hancement of tyrosine phosphorylation.  The
findings that IFN-γ activated the protein
tyrosine kinases that phosphorylate the cellular
substrates and induce MHC class I and II
molecules suggest that tyrosine phosphoryla-
tion is involved in the induction of the expres-
sion of MHC molecules on HLC-1 cells by
IFN-γ.  Therefore, a JAK-STAT signal trans-
duction pathway must be involved in the IFN-γ-
induced expression of MHC class I and II
molecules.  However, we cannot exclude the
possibility of involvement by other pathways
because herbimycin A did not completely in-
hibit IFN-γ-inducible expression of MHC mole-
cules.  While the expression of MHC molecules
is known to be regulated by other cytokines
such as tumor necrosis factor alpha and inter-
leukin 1 alpha (Seong et al., 1991; Sedlak et al.,
1992; Wolchok and Vilcek, 1992), little is
known about the signal transduction mecha-
nisms which induce MHC antigens by these
cytokines.  Further, there are some reports
which state that c-myc oncogene regulates the
expression of MHC molecules on cancer cells
(Versteeg et al., 1988; Gaforio et al., 1991).  We
think it should also be necessary in the future to
clarify the signal transduction pathways by
these cytokines and oncogenes for understand-
ing the more detailed mechanisms which induce
MHC molecules.
The expression of MHC class I and II anti-
gens on cancer cells are involved in a variety of
immune functions affecting tumor immunity.
Cancer cells have reduced expression of MHC
molecules enabling them to escape from the
host’s immunosurveillance system (Goodenow
et al., 1985; Festenstein et al., 1986).  There-
fore, we think it is important to elucidate both
the mechanisms modulating the expression of
MHC molecules and the methods restoring the
expression of these molecules on cancer cells
for improvement of clinical problems about
tumor immunity.  In the present study, we eluci-
dated the fact that tyrosine phosphorylation
played an important role as the mechanism
which restores the expression of MHC mole-
cules on cancer cells.
In conclusion, tyrosine phosphorylation is
considered to be an essential factor in the IFN-
γ-induced expression of MHC class I and II
molecules on HLC-1 cells.
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